Cargando…

Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis

BACKGROUND: Information on the epidemiology of uncommon EGFR mutations including exon 20 insertions amongst non-small-cell lung cancer (NSCLC) is lacking. OBJECTIVE: The objective of this pragmatic literature review (PLR) and meta-analysis was to generate robust prevalence and incidence estimates ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Sanden, Suzy, Murton, Molly, Bobrowska, Anna, Rahhali, Nora, Sermon, Jan, Rodrigues, Bernardo, Goff-Leggett, Danielle, Chouaid, Christos, Sebastian, Martin, Greystoke, Alastair
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995294/ https://www.ncbi.nlm.nih.gov/pubmed/35226283 http://dx.doi.org/10.1007/s11523-022-00868-z

Ejemplares similares

An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
por: Chouaid, Christos, et al.
Publicado: (2023)

Amivantamab Compared with Real-World Physician’s Choice after Platinum-Based Therapy from a Pan-European Chart Review of Patients with Lung Cancer and Activating EGFR Exon 20 Insertion Mutations
por: Christopoulos, Petros, et al.
Publicado: (2023)

Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review
por: Murton, Molly, et al.
Publicado: (2020)

Successful Treatment of Lung Adenocarcinoma with Epidermal Growth Factor Receptor Compound Mutations Involving Exon 19 Deletion and Exon 20 Insertion by Afatinib
por: Ikeuchi, Tomoyuki, et al.
Publicado: (2019)

A Novel Insertion Mutation on Exon 20 of Epidermal Growth Factor Receptor, Conferring Resistance to Erlotinib
por: Khan, Nawazish A., et al.
Publicado: (2014)

Targeted screening in the UK: A narrow concept with broad application
por: Bobrowska, Anna, et al.
Publicado: (2022)

Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review
por: Atsou, Kokuvi, et al.
Publicado: (2011)

Sensitivity of epidermal growth factor receptor and ErbB2 exon 20 insertion mutants to Hsp90 inhibition
por: Xu, W, et al.
Publicado: (2007)

Good response with durvalumab after chemoradiotherapy for epidermal growth factor receptor exon 20 insertion adenocarcinoma: A case report
por: Matsuura, Shun, et al.
Publicado: (2020)

Frequency, underdiagnosis, and heterogeneity of epidermal growth factor receptor exon 20 insertion mutations using real‐world genomic datasets
por: Viteri, Santiago, et al.
Publicado: (2022)

Transposon insertion mapping with PIMMS – Pragmatic Insertional Mutation Mapping System
por: Blanchard, Adam M., et al.
Publicado: (2015)

Not All EGFR Exon 20 Insertions Are Created Equal
por: Lin, Yen-Ting, et al.
Publicado: (2020)

Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations
por: Wang, Yue, et al.
Publicado: (2020)

Burden and Treatment of Achondroplasia: A Systematic Literature Review
por: Murton, Molly C., et al.
Publicado: (2023)

Exons 5–15 of Kazrin Are Dispensable for Murine Epidermal Morphogenesis and Homeostasis
por: Chhatriwala, Mariya K, et al.
Publicado: (2012)

Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2
por: Bernard, Veronica, et al.
Publicado: (2009)

Genome editing through large insertion leads to the skipping of targeted exon
por: Uddin, Borhan, et al.
Publicado: (2015)

Identification of novel exonic mobile element insertions in epithelial ovarian cancers
por: Hayano, Takahide, et al.
Publicado: (2015)

Osimertinib as treatment for EGFR exon 20 insertion-positive lung adenocarcinoma
por: Murano, Chihiro, et al.
Publicado: (2019)

An exonic insertion in the NAGLU gene causing Mucopolysaccharidosis IIIB in Schipperke dogs
por: Raj, Karthik, et al.
Publicado: (2020)

Structural Basis for the Functional Changes by EGFR Exon 20 Insertion Mutations
por: Tamirat, Mahlet Z., et al.
Publicado: (2021)

EGFR Exon 20 Insertion Mutations in Sinonasal Squamous Cell Carcinoma
por: Pacini, Laura, et al.
Publicado: (2022)

The budget impact of introducing mobocertinib for the postplatinum treatment of advanced non–small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion mutations
por: Hernandez, Luis, et al.
Publicado: (2023)

An exonic insertion within Tex14 gene causes spermatogenic arrest in pigs
por: Sironen, Anu, et al.
Publicado: (2011)

Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
por: Pacini, Laura, et al.
Publicado: (2021)

EGFR exon 20 insertion mutations in non-small cell lung cancer
por: Wang, Fenfang, et al.
Publicado: (2020)

EGFR Testing Patterns and Detection of EGFR Exon 20 Insertions in the United States
por: Lin, Huamao M., et al.
Publicado: (2022)

Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
por: Zhang, Shannon S, et al.
Publicado: (2021)

Template-jumping prime editing enables large insertion and exon rewriting in vivo
por: Zheng, Chunwei, et al.
Publicado: (2023)

Identification of Recurrent Insertions and Deletions in Exon 18 and 19 of Human Epidermal Growth Factor Receptor 2 as Potential Drivers in Non–Small-Cell Lung Cancer and Other Cancer Types
por: Yin, Yan, et al.
Publicado: (2022)

Health care for irregular migrants: pragmatism across Europe. A qualitative study
por: Dauvrin, Marie, et al.
Publicado: (2012)

Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
por: Vyse, Simon, et al.
Publicado: (2019)

In Silico identification of a common mobile element insertion in exon 4 of RP1
por: Won, Dongju, et al.
Publicado: (2021)

Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2023)

ETV6 fusions from insertions of exons 3-5 in pediatric hematologic malignancies
por: Mueller, Sarah B., et al.
Publicado: (2023)

Clinical relevance of nalmefene versus placebo in alcohol treatment: Reduction in mortality risk
por: Roerecke, Michael, et al.
Publicado: (2015)

Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
por: Chowdhury, Simon, et al.
Publicado: (2019)

Novel insertion in exon 5 of the TCOF1 gene in twin sisters with Treacher Collins syndrome
por: Marszałek-Kruk, Bożena Anna, et al.
Publicado: (2012)

Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib
por: Agbarya, Abed, et al.
Publicado: (2014)

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer
por: Fang, Wenfeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_e3f99qvikemp1fi9mmkebfrcnd